107
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Long-term follow-up of previously treated and treatment-naïve patients who received tositumomab and I-131 tositumomab

, , , &
Pages 1238-1240 | Received 09 Mar 2015, Accepted 05 Aug 2015, Published online: 23 Dec 2015
 

Acknowledgements

Medical writing assistance provided by Joanne Ashworth, Fishawack Indicia Ltd. This study was funded by GSK who were involved in the study design and data analysis.

Potential conflict of interest

Disclosure forms provided by the authors are available with the full text of this article at http://dx.doi.org/10.3109/10428194.2015.1082179.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.